Avricore Health Inc. Files September 2024 6-K Report
Ticker: AVCRF · Form: 6-K · Filed: Oct 7, 2024 · CIK: 1355736
| Field | Detail |
|---|---|
| Company | Avricore Health INC. (AVCRF) |
| Form Type | 6-K |
| Filed Date | Oct 7, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, compliance
TL;DR
AVRICORE HEALTH (AVRX) filed its monthly 6-K report for September 2024. No major news, just routine compliance.
AI Summary
Avricore Health Inc. filed a Form 6-K on October 7, 2024, for the month of September 2024. The company, formerly known as Vanc Pharmaceuticals Inc. and NUVA Pharmaceuticals Inc., is reporting its activities as a foreign private issuer. The filing does not contain specific financial figures or significant business updates for September.
Why It Matters
This filing serves as a routine update for investors, indicating the company's ongoing compliance and reporting activities as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine operational report and does not contain significant financial or strategic information that would immediately impact the company's risk profile.
Key Players & Entities
- Avricore Health Inc. (company) — Registrant
- Vanc Pharmaceuticals Inc. (company) — Former company name
- NUVA Pharmaceuticals Inc. (company) — Former company name
- ALDA Pharmaceuticals Corp. (company) — Former company name
- October 7, 2024 (date) — Filing date
- September 2024 (date) — Reporting period
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the company has made or is required to make public pursuant to the laws of its home country, or that it has filed or will file with a stock exchange.
When was this Form 6-K filed?
This Form 6-K was filed on October 7, 2024.
What period does this report cover?
This report covers the month of September 2024.
What were Avricore Health Inc.'s former company names?
Avricore Health Inc. was formerly known as Vanc Pharmaceuticals Inc., NUVA Pharmaceuticals Inc., and ALDA Pharmaceuticals Corp.
Does this filing indicate any new financial results or significant business developments?
No, this Form 6-K is a routine report for the month of September 2024 and does not contain specific financial results or new business developments.
Filing Stats: 379 words · 2 min read · ~1 pages · Grade level 17.3 · Accepted 2024-10-04 17:50:35
Filing Documents
- form6-k.htm (6-K) — 22KB
- ex1.htm (EX-1) — 19KB
- ex1_001.jpg (GRAPHIC) — 10KB
- 0001493152-24-039596.txt ( ) — 56KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AVRICORE HEALTH INC. Date: October 4, 2024 By “Kiki Smith” Kiki Smith Chief Financial Officer SEC1815(04-09) Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number